Correction to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer
Main Authors: | Christine Stürken, Volker Möbus, Karin Milde-Langosch, Sabine Schmatloch, Peter A. Fasching, Josef Rüschoff, Elmar Stickeler, Rolf-Peter Henke, Carsten Denkert, Lars Hanker, Christian Schem, Valentina Vladimirova, Thomas Karn, Valentina Nekljudova, Claus-Henning Köhne, Frederik Marmé, Udo Schumacher, Sibylle Loibl, Volkmar Müller |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | BMC Cancer |
Online Access: | https://doi.org/10.1186/s12885-021-08754-z |
Similar Items
-
TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer
by: Christine Stürken, et al.
Published: (2021-08-01) -
Clinical Relevance of Collagen Protein Degradation Markers C3M and C4M in the Serum of Breast Cancer Patients Treated with Neoadjuvant Therapy in the GeparQuinto Trial
by: Malgorzata Banys-Paluchowski, et al.
Published: (2019-08-01) -
Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial
by: Ines Stevic, et al.
Published: (2018-10-01) -
Tgif1 and Tgif2 Regulate Axial Patterning in Mouse.
by: Tiffany A Melhuish, et al.
Published: (2016-01-01) -
MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial.
by: Paul Jank, et al.
Published: (2020-01-01)